Literature DB >> 11096474

Beta Blockade Improves Survival in Patients with Congestive Heart Failure.

.   

Abstract

Entities:  

Year:  1999        PMID： 11096474     DOI： 10.1007/s11936-999-0013-9

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN： 1092-8464


× No keyword cloud information.
  10 in total

1.  Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators.

Authors:  F Boutitie; J P Boissel; S J Connolly; A J Camm; J A Cairns; D G Julian; M Gent; M J Janse; P Dorian; G Frangin
Journal:  Circulation       Date:  1999-05-04       Impact factor: 29.690

2.  Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials.

Authors:  P A Heidenreich; T T Lee; B M Massie
Journal:  J Am Coll Cardiol       Date:  1997-07       Impact factor: 24.094

Review 3.  Beta-blockers for heart failure: where are we now?

Authors:  S S Gottlieb
Journal:  Curr Opin Cardiol       Date:  1994-05       Impact factor: 2.161

4.  Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

Authors:  F Waagstein; A Hjalmarson; E Varnauskas; I Wallentin
Journal:  Br Heart J       Date:  1975-10

5.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Authors: 
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

6.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

Authors: 
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

Review 7.  The role of third-generation beta-blocking agents in chronic heart failure.

Authors:  M R Bristow; R L Roden; B D Lowes; E M Gilbert; E J Eichhorn
Journal:  Clin Cardiol       Date:  1998-12       Impact factor: 2.882

8.  Design of the Beta-Blocker Evaluation Survival Trial (BEST). The BEST Steering Committee.

Authors: 
Journal:  Am J Cardiol       Date:  1995-06-15       Impact factor: 2.778

9.  Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.

Authors:  F Waagstein; M R Bristow; K Swedberg; F Camerini; M B Fowler; M A Silver; E M Gilbert; M R Johnson; F G Goss; A Hjalmarson
Journal:  Lancet       Date:  1993-12-11       Impact factor: 79.321

10.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Authors:  M Packer; M R Bristow; J N Cohn; W S Colucci; M B Fowler; E M Gilbert; N H Shusterman
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.